XT
KALV

XTX Topco’s KalVista Pharmaceuticals KALV Stock Holding History

XTX Topco’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Buy
79,118
+52,610
+198% +$848K 0.03% 1026
2025
Q4 		$428K Buy
+26,508
New +$351K 0.01% 1752
2025
Q1 		– Sell
-31,573
Closed -$267K – 2742
2024
Q4 		$267K Buy
+31,573
New +$327K 0.02% 1316

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

XTX Topco's KALV Position: Q1 2026 in Review

XTX Topco increased its KalVista Pharmaceuticals (KALV) stake by 198% in Q1 2026, buying an estimated $848K and bringing the position to 79,118 shares worth $1.59M. The position accounts for 0.03% of the portfolio, ranked #1026.

XTX Topco first reported a position in KALV in Q4 2024 and has held it in 3 quarters since. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • XTX Topco held 79,118 shares of KalVista Pharmaceuticals worth $1.59M as of Q1 2026.
  • XTX Topco bought 52,610 KalVista Pharmaceuticals shares in Q1 2026, an estimated $848K.
  • KalVista Pharmaceuticals made up 0.03% of XTX Topco's portfolio in Q1 2026, its #1026 holding.
  • XTX Topco first reported a position in KalVista Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.